“…TXA is a lysine derivative 10 that can be inhaled, applied topically, or given by intravenous (IV) administration 3,11 in order to systemically manage patient hemorrhage. Depending on the specific case, dosing recommendations have ranged from administering TXA at a dose of 15 mg/kg of body weight 12 to administering a bolus ranging from 1 to 4 g of TXA 13,14 . Some studies have experimented with providing multiple doses of TXA but have generally found similar outcomes between single and multiple-dose groups 15 .…”